COWS:NSD-Amplify Cash Flow Dividend Leaders ETF (USD)

ETF | Others |

Last Closing

USD 30.18

Change

0.00 (0.00)%

Market Cap

USD 0.02B

Volume

2.86K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The fund invests at least 80% of its net assets in securities that comprise the index, which will primarily include dividend paying U.S. equity securities. The index is based on a proprietary methodology developed and maintained by Kelly Indexes, LLC, an affiliate of Kelly Strategic Management, LLC, an investment sub-adviser to the fund. The fund is non-diversified.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-20 )

Largest Industry Peers for Others

ETFs Containing COWS

HCOW Amplify Cash Flow High In.. 98.30 % 0.00 %

N/A

USD 3.29M

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 11.20% 63% D 59% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.20% 63% D 59% D-
Trailing 12 Months  
Capital Gain 26.17% 62% D 58% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 26.17% 63% D 58% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 1.77% 59% D- 45% F
Dividend Return 1.77% 54% F 41% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 6.06% 76% C+ 92% A
Risk Adjusted Return 29.28% 53% F 62% D
Market Capitalization 0.02B 38% F 16% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.